Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Biomea Fusion, Inc.

CIK 1840439Updated Nov 12, 2026

BMEA price & chart

Provider market data

Loading TradingView…

NASDAQ:BMEA on TradingView ↗

TradingView · Data may be delayed

About the company

Biomea Fusion is a clinical-stage diabetes and obesity medicines company focused on the development of its oral small molecule therapeutic candidates, icovamenib and BMF-650, for diabetes and obesity. These programs target metabolic disorders, a global health challenge affecting nearly half of Americans and one-fifth of the world’s population. Biomea’s mission is to deliver transformative treatments that restore health for patients living with diabetes, obesity, and related conditions. We aim to cure.

8-K · 2026-11-10 · 0001193125-26-455557

Company description from the cited filing.

Financials

FY 2025 · USD
Revenue— · FY 2025
Net income-61,797,000USD · FY 2025
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

Operating income-83,512,000USD · FY 2025
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

Diluted EPS-1.18USD per share · FY 2025
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD55,187,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

110,419,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

36,873,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

73,163,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

136,164,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

46,385,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

55,055,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

168,494,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

58,572,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

79,938,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

199,927,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

129,307,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Property, Plant and Equipment, NetUSD200,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

4,228,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

47,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

2,831,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

4,445,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

67,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

3,298,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

4,806,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

153,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

3,766,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

5,159,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

5,841,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD46,642,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

87,952,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2024-09-30

34,824,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

56,224,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2025-06-30

113,286,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2024-06-30

44,693,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

35,864,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2025-03-31

144,918,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2024-03-31

55,812,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

58,279,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

176,866,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

111,899,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Assets, CurrentUSD49,440,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

93,598,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

36,428,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

64,663,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

116,288,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

46,318,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

44,685,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

147,566,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

58,050,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

68,332,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

179,181,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

117,819,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD2,798,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

5,646,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

1,235,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

8,439,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

3,002,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

1,256,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

8,821,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

2,648,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

2,238,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

10,053,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

2,315,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

4,770,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD5,178,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

7,595,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

—5,296,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

8,315,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

—6,086,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

9,013,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

0
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

6,852,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

9,714,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

2,151,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Other Assets, NoncurrentUSD0
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

4,629,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

398,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

4,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

6,747,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

—617,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

6,740,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

0
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

619,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

5,503,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

—
LIABILITIES AND EQUITY
LiabilitiesUSD39,568,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

34,447,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

24,736,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

45,653,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

32,216,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

27,666,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

26,318,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

33,180,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

29,020,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

28,365,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

30,690,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

20,768,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD6,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

4,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

7,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

6,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

4,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

7,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

4,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

4,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

7,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

4,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

4,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

3,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Additional Paid in CapitalUSD469,273,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

433,917,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

481,921,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

464,757,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

429,106,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

480,175,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

445,246,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

423,196,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

478,593,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

438,820,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

418,058,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

240,107,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-453,660,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

-357,949,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

-469,791,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

-437,253,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

-325,162,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

-461,463,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

-416,513,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

-287,886,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

-449,048,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

-387,251,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

-248,825,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

-131,570,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD———————————-1,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD15,619,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

75,972,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2024-09-30

12,137,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

27,510,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2025-06-30

103,948,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2024-06-30

18,719,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

28,737,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2025-03-31

135,314,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2024-03-31

29,552,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

51,573,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

169,237,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

108,539,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Liabilities and EquityUSD55,187,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

110,419,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

36,873,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

73,163,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

136,164,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

46,385,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

55,055,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

168,494,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

58,572,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

79,938,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

199,927,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

129,307,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD15,565,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

27,572,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

10,483,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

17,568,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

25,163,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

9,294,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

19,817,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

25,254,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

11,101,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

21,673,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

22,860,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

19,101,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Operating Lease, Liability, CurrentUSD787,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

2,692,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

877,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

755,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

3,289,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

1,239,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

1,426,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

3,166,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

1,461,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

2,079,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

2,466,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

618,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Accounts Payable, CurrentUSD6,397,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

8,987,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

3,306,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

8,378,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

5,828,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

4,613,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

7,707,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

4,709,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

3,233,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

12,932,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

6,851,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

6,826,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD6,089,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

6,875,000
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

0
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

6,299,000
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

7,053,000
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

0
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

6,501,000
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

7,926,000
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

128,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

6,692,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

7,830,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

1,667,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Additional Financial Items
Dividends PayableUSD0
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

0
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

0
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

0
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

0
Source

10-Q · 2024-07-31 · 0000950170-24-088584

As of 2024-06-30

0
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

0
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

0
Source

10-Q · 2024-05-02 · 0000950170-24-052082

As of 2024-03-31

0
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

0
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

0
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

0
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Short-term InvestmentsUSD———————————1,150,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————-12,415,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

-29,262,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

-61,797,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

-138,426,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

-117,255,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

-81,828,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD——————1,582,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

3,169,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

9,520,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

19,094,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

14,131,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

10,336,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts PayableUSD——————1,380,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

-5,220,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

-9,700,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

6,088,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

2,562,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

2,960,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-11,669,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

-25,667,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

-70,371,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

-119,894,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

-96,592,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

-62,417,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————550,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

0
Source

10-Q · 2025-05-05 · 0000950170-25-063543

2025-01-01 to 2025-03-31

—-362,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

-2,220,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

27,341,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD———————0
Source

10-Q · 2025-05-05 · 0000950170-25-063543

2025-01-01 to 2025-03-31

—362,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

3,370,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

1,030,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD———————3,252,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

67,904,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

1,668,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

163,798,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

1,239,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-11,119,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

-22,415,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

-2,467,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

-118,588,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

64,986,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

-33,837,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——47,011,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

88,321,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2024-09-30

35,193,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

56,593,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2025-06-30

45,062,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

36,233,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2025-03-31

56,181,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

58,648,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

177,236,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

112,250,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

Additional Financial Items
DepreciationUSD——400,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

400,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

—500,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

46,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

468,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

1,409,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

1,748,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

1,515,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

691,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Dividends PayableUSD——0
Source

10-Q · 2025-11-04 · 0001193125-25-264679

As of 2025-09-30

0
Source

10-Q · 2024-10-29 · 0000950170-24-118366

As of 2024-09-30

0
Source

10-Q · 2026-08-05 · 0001193125-26-335085

As of 2026-06-30

0
Source

10-Q · 2025-08-05 · 0000950170-25-103041

As of 2025-06-30

0
Source

10-Q · 2026-05-11 · 0001193125-26-217074

As of 2026-03-31

0
Source

10-Q · 2025-05-05 · 0000950170-25-063543

As of 2025-03-31

0
Source

10-K · 2026-03-24 · 0001193125-26-121825

As of 2025-12-31

0
Source

10-K · 2025-03-31 · 0000950170-25-047775

As of 2024-12-31

0
Source

10-K · 2024-03-28 · 0000950170-24-038026

As of 2023-12-31

0
Source

10-K · 2023-03-28 · 0000950170-23-010312

As of 2022-12-31

General and Administrative ExpenseUSD——4,199,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

6,795,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

3,624,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

4,710,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

3,654,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

6,815,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

19,328,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

25,985,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

23,589,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

20,921,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-16,407,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

-32,787,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

-8,328,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

-20,740,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

-12,415,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

-29,262,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

-61,797,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

-138,426,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

-117,255,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

-81,828,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Operating ExpensesUSD——20,805,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

34,039,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

12,766,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

21,276,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

12,774,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

29,712,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

83,512,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

144,070,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

126,135,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

83,634,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Proceeds from Issuance of Common StockUSD———————3,257,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

4,908,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

—161,803,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

—
Gain (Loss) on Disposition of Property Plant Equipment—————
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

——
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

—————
Payments of Financing Costs————————
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

————
Proceeds from Stock Options Exercised————————
Source

10-Q · 2025-05-05 · 0000950170-25-063543

2025-01-01 to 2025-03-31

————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Operating Income (Loss)USD——-20,805,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

-34,039,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

-12,766,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

-21,276,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

-12,774,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

-29,712,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

-83,512,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

-144,070,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

-126,135,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

-83,634,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-16,407,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

-32,787,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

-8,328,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

-20,740,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

-12,415,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

-29,262,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

-61,797,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

-138,426,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

-117,255,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

-81,828,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0.27
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

-0.91
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

-0.12
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

-0.51
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

-0.17
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

-0.8
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

-1.18
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

-3.83
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

-3.44
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

-2.8
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-0.27
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

-0.91
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

-0.12
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

-0.51
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

-0.17
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

-0.8
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

-1.18
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

-3.83
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

-3.44
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

-2.8
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——59,848,325
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

36,220,736
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

72,360,235
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

40,630,403
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

72,299,440
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

36,627,148
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

52,228,068
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

36,105,671
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

34,106,923
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

29,271,777
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——59,848,325
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

36,220,736
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

72,360,235
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

40,630,403
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

72,299,440
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

36,627,148
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

52,228,068
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

36,105,671
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

34,106,923
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

29,271,777
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Additional Financial Items
General and Administrative ExpenseUSD——4,199,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

6,795,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

3,624,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

4,710,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

3,654,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

6,815,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

19,328,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

25,985,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

23,589,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

20,921,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Interest and Other IncomeUSD——4,398,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

1,252,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

319,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

309,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

430,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

450,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

1,858,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

5,644,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

8,880,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

1,806,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Interest Income (Expense), NetUSD——4,398,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

1,252,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

319,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

309,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

430,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

450,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

1,858,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

———
Operating ExpensesUSD——20,805,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

34,039,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

12,766,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

21,276,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

12,774,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

29,712,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

83,512,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

144,070,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

126,135,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

83,634,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD——14,401,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2025-07-01 to 2025-09-30

27,244,000
Source

10-Q · 2025-11-04 · 0001193125-25-264679

2024-07-01 to 2024-09-30

9,142,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2026-04-01 to 2026-06-30

16,566,000
Source

10-Q · 2026-08-05 · 0001193125-26-335085

2025-04-01 to 2025-06-30

9,120,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2026-01-01 to 2026-03-31

22,897,000
Source

10-Q · 2026-05-11 · 0001193125-26-217074

2025-01-01 to 2025-03-31

61,979,000
Source

10-K · 2026-03-24 · 0001193125-26-121825

2025-01-01 to 2025-12-31

118,085,000
Source

10-K · 2025-03-31 · 0000950170-25-047775

2024-01-01 to 2024-12-31

102,546,000
Source

10-K · 2024-03-28 · 0000950170-24-038026

2023-01-01 to 2023-12-31

62,713,000
Source

10-K · 2023-03-28 · 0000950170-23-010312

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

bmea-ex99_1.htm · 8-K · 2026-11-10

Exhibit 99.1 Biomea Fusion Reports Third Quarter 2026 Financial Results and Corporate Highlights • Completed enrollment in the Phase II COVALENT-211 clinical trial evaluating icovamenib in patients with insulin-deficient type 2 diabetes (“T2D”); topline data expected in the first quarter of 2027 • Enrollment ongoing in the Phase II COVALENT-212 clinical trial evaluating icovamenib in patients with T2D not achieving glycemic targets on GLP-1 receptor agonist (“GLP-1 RA”)-based therapy; topline…

8-K · 2026-11-10 · 0001193125-26-455557

Read attachment ↗
d158362dex991.htm · 8-K · 2026-10-14

Exhibit 99.1 GLP-131 Phase 1 Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants Week 4 Topline Results October 13, 2026 Legal Disclaimer & Forward-looking Statements Certain statements in this presentation and the accompanying oral commentary are forward-looking statements. These statements relate to future events or the future business and financial performance of Biomea Fusion, Inc. (the “Company”) and involve known and unknown risks, uncertainties, and other factors…

8-K · 2026-10-14 · 0001193125-26-420684

Read attachment ↗
d158362dex992.htm · 8-K · 2026-10-14

Exhibit 99.2 Biomea Fusion Announces Phase 1 Results for BMF-650, its Investigational Next-Generation Oral Small Molecule GLP-1 Receptor Agonist Mean weight reduction ranged from 1.5% to 3.2% at Day 29 across Cohorts 1-4, compared with 0.1% for pooled placebo. No severe or serious TEAEs, no TEAE-related dose modifications, and no TEAE-related discontinuations among all BMF-650-treated MAD participants. A rapid one-step titration to the target dose of 400 mg QD in Cohort 5 was equa…

8-K · 2026-10-14 · 0001193125-26-420684

Read attachment ↗
bmea-ex99_1.htm · 8-K · 2026-08-05

EX-99.1 2 bmea-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Biomea Fusion Reports Second Quarter 2026 Financial Results and Corporate Highlights • Enrollment ongoing for the Phase II COVALENT-211 clinical trial in patients with insulin deficiency in Type 2 diabetes ("T2D"); data expected in the first quarter of 2027 • Enrollment also ongoing for the Phase II COVALENT-212 clinical trial in patients with T2D not achieving glycemic targets while on glucagon-like peptide-1 receptor agonists ("GLP…

8-K · 2026-08-05 · 0001193125-26-335073

Read attachment ↗
bmea-ex99_1.htm · 8-K · 2026-05-11

EX-99.1 2 bmea-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights • Successfully completed chronic toxicology studies for icovamenib, providing the nonclinical support for advancing to chronic clinical dosing, beyond the 12‑week clinical dosing that has been used to date • Topline data reported from the Phase II COVALENT-112 clinical trial of icovamenib in type 1 diabetes (“T1D”), supporting proposed mechanism of ac…

8-K · 2026-05-11 · 0001193125-26-217037

Read attachment ↗
d142809dex991.htm · 8-K · 2026-04-28

EX-99.1 2 d142809dex991.htm EX-99.1 EX-99.1 COVALENT-112 Topline Results BIOMEA FUSION CONFERENCE CALL 28 APRIL 2026 Icovamenib in Type 1 Diabetes Exhibit 99.1 Certain statements in this presentation and the accompanying oral commentary are forward-looking statements. These statements relate to future events or the future business and financial performance of Biomea Fusion, Inc. (the “Company”) and involve known and unknown risks, uncertainties, and other factors that may cause the actual …

8-K · 2026-04-28 · 0001193125-26-183710

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.